ATAI
Price
$4.52
Change
-$0.07 (-1.53%)
Updated
Sep 3, 04:59 PM (EDT)
Capitalization
968.81M
75 days until earnings call
MNMD
Price
$9.06
Change
-$0.07 (-0.77%)
Updated
Sep 3 closing price
Capitalization
689.36M
69 days until earnings call
Interact to see
Advertisement

ATAI vs MNMD

Header iconATAI vs MNMD Comparison
Open Charts ATAI vs MNMDBanner chart's image
ATAI Life Sciences
Price$4.52
Change-$0.07 (-1.53%)
Volume$31.81K
Capitalization968.81M
Mind Medicine (MindMed)
Price$9.06
Change-$0.07 (-0.77%)
Volume$666.84K
Capitalization689.36M
ATAI vs MNMD Comparison Chart in %
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. MNMD commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Buy and MNMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (ATAI: $4.59 vs. MNMD: $9.13)
Brand notoriety: ATAI and MNMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 46% vs. MNMD: 84%
Market capitalization -- ATAI: $968.81M vs. MNMD: $689.36M
ATAI [@Biotechnology] is valued at $968.81M. MNMD’s [@Biotechnology] market capitalization is $689.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileMNMD’s FA Score has 0 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • MNMD’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATAI and MNMD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 3 TA indicator(s) are bullish while MNMD’s TA Score has 4 bullish TA indicator(s).

  • ATAI’s TA Score: 3 bullish, 5 bearish.
  • MNMD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MNMD is a better buy in the short-term than ATAI.

Price Growth

ATAI (@Biotechnology) experienced а -4.97% price change this week, while MNMD (@Biotechnology) price change was -8.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +16.10%, and the average quarterly price growth was +32.67%.

Reported Earning Dates

ATAI is expected to report earnings on Nov 18, 2025.

MNMD is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATAI($969M) has a higher market cap than MNMD($689M). ATAI YTD gains are higher at: 245.113 vs. MNMD (31.178). MNMD has higher annual earnings (EBITDA): -110.19M vs. ATAI (-115.96M). MNMD has more cash in the bank: 183M vs. ATAI (95.9M). ATAI has less debt than MNMD: ATAI (9.22M) vs MNMD (41.2M). ATAI has higher revenues than MNMD: ATAI (2.31M) vs MNMD (0).
ATAIMNMDATAI / MNMD
Capitalization969M689M141%
EBITDA-115.96M-110.19M105%
Gain YTD245.11331.178786%
P/E RatioN/AN/A-
Revenue2.31M0-
Total Cash95.9M183M52%
Total Debt9.22M41.2M22%
FUNDAMENTALS RATINGS
ATAI vs MNMD: Fundamental Ratings
ATAI
MNMD
OUTLOOK RATING
1..100
1774
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
36
Fair valued
PROFIT vs RISK RATING
1..100
8493
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
3544
P/E GROWTH RATING
1..100
13100
SEASONALITY SCORE
1..100
n/a35

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MNMD's Valuation (36) in the null industry is somewhat better than the same rating for ATAI (73) in the Miscellaneous Commercial Services industry. This means that MNMD’s stock grew somewhat faster than ATAI’s over the last 12 months.

ATAI's Profit vs Risk Rating (84) in the Miscellaneous Commercial Services industry is in the same range as MNMD (93) in the null industry. This means that ATAI’s stock grew similarly to MNMD’s over the last 12 months.

ATAI's SMR Rating (98) in the Miscellaneous Commercial Services industry is in the same range as MNMD (98) in the null industry. This means that ATAI’s stock grew similarly to MNMD’s over the last 12 months.

ATAI's Price Growth Rating (35) in the Miscellaneous Commercial Services industry is in the same range as MNMD (44) in the null industry. This means that ATAI’s stock grew similarly to MNMD’s over the last 12 months.

ATAI's P/E Growth Rating (13) in the Miscellaneous Commercial Services industry is significantly better than the same rating for MNMD (100) in the null industry. This means that ATAI’s stock grew significantly faster than MNMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATAIMNMD
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
82%
Bullish Trend 13 days ago
84%
Declines
ODDS (%)
Bearish Trend 20 days ago
85%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DSCIX14.740.03
+0.20%
Dana Epiphany Small Cap Eq Instl
MAPLX28.56N/A
N/A
Morgan Stanley Inst Advantage L
BMSLX15.28-0.08
-0.52%
MFS Blended Research Mid Cap Eq I
SAMKX39.27-0.24
-0.61%
SA US Core Market
MFRJX62.53-0.40
-0.64%
MFS Research R4

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with MNMD. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
+0.22%
MNMD - ATAI
51%
Loosely correlated
+2.82%
RXRX - ATAI
42%
Loosely correlated
-0.85%
CYBN - ATAI
41%
Loosely correlated
-16.58%
SYRE - ATAI
40%
Loosely correlated
+0.85%
CRSP - ATAI
39%
Loosely correlated
+1.60%
More

MNMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNMD has been loosely correlated with OCUL. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if MNMD jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNMD
1D Price
Change %
MNMD100%
+2.82%
OCUL - MNMD
53%
Loosely correlated
+4.01%
RXRX - MNMD
51%
Loosely correlated
-0.85%
ATAI - MNMD
51%
Loosely correlated
+0.22%
EYPT - MNMD
50%
Loosely correlated
+1.38%
RCUS - MNMD
50%
Loosely correlated
+2.08%
More